Clinical Trial Update: Study of AXT-1003 in Subjects With Advanced Malignant Tumors. [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for AXT-1003 in subjects with advanced malignant tumors. The study is currently recruiting for Non-Hodgkin lymphoma and advanced s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma
• Solid Tumor

Drugs mentioned

• AXT-1003

Snippet

Sponsor: Axter Therapeutics (Beijing) Co., Ltd | Conditions: Non-Hodgkin Lymphoma, Advanced Solid Tumor | Phase 1 | Status: RECRUITING